You are here » Home » Company » Aurobindo Pharma Ltd

Aurobindo Pharma Ltd.

BSE: 524804 Sector: Health care
NSE: AUROPHARMA ISIN Code: INE406A01037
BSE 00:00 | 14 Oct 726.65 -1.95
(-0.27%)
OPEN

735.00

HIGH

736.65

LOW

724.55

NSE 00:00 | 14 Oct 727.15 -1.40
(-0.19%)
OPEN

734.65

HIGH

737.00

LOW

724.20

OPEN 735.00
PREVIOUS CLOSE 728.60
VOLUME 113670
52-Week high 1063.75
52-Week low 660.10
P/E 16.22
Mkt Cap.(Rs cr) 42,574
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 735.00
CLOSE 728.60
VOLUME 113670
52-Week high 1063.75
52-Week low 660.10
P/E 16.22
Mkt Cap.(Rs cr) 42,574
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd

Aurobindo Pharma Limited (APL) one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy Mr. K.Nityananda Reddy and a small highly committed group of professionals founded it. APL is developing manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives) in...> More

Aurobindo Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   42,574
EPS - TTM () [*S] 44.80
P/E Ratio (X) [*S] 16.22
Face Value ()   1
Latest Dividend (%)   150.00
Latest Dividend Date 27 Aug 2021
Dividend Yield (%) 0.55
Book Value / Share () [*S] 271.78
P/B Ratio () [*S] 2.67
[*C] Consolidated     [*S] Standalone    

Aurobindo Pharma Ltd - Financial Results

Particulars ( cr) Jun 2021 Jun 2020 % Chg
Net Sales 5701.98 5924.78 -3.76
Other Income 109.9 115.59 -4.92
Total Income 5811.88 6040.37 -3.78
Total Expenses 4501.6 4679.43 -3.8
Operating Profit 1310.28 1360.94 -3.72
Net Profit 769.97 783.16 -1.68
Equity Capital 58.59 58.59 -
> More on Aurobindo Pharma Ltd Financials Results

Aurobindo Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alkem Lab 3893.40 -1.21 46545.60
Abbott India 21544.00 -0.12 45781.00
Lupin 946.10 -1.81 42957.67
Aurobindo Pharma 726.65 -0.27 42574.42
Biocon 347.80 -1.26 41756.87
Laurus Labs 650.95 2.58 34929.98
Ipca Labs. 2421.70 2.57 30719.27
> More on Aurobindo Pharma Ltd Peer Group

Aurobindo Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 51.83
Banks/FIs 0.00
FIIs 21.71
Insurance 4.54
Mutual Funds 9.28
Indian Public 9.59
Custodians 0.00
Other 1.34
> More on Aurobindo Pharma Ltd Share Holding Pattern

Aurobindo Pharma Ltd - Research Reports

Date Broker Action Price Report
01/06/2021 Cebtrum Buy 1001 PDF IconDetails
28/09/2020 Motilal Oswal Buy 772 PDF IconDetails
21/08/2020 Centrum Broking Buy 865 PDF IconDetails
04/06/2020 ICICI Direct Buy 750 PDF IconDetails
13/05/2020 HDFC Securities Buy 691 PDF IconDetails
> More on Aurobindo Pharma Ltd Research Reports

Aurobindo Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 1.01% 1.05% 2.73% 3.08%
1 Month -2.87% -2.79% 5.25% 5.52%
3 Month -24.55% -24.49% 15.88% 15.67%
6 Month -20.13% -20.03% 26.29% 26.43%
1 Year -10.30% -10.27% 50.28% 53.19%
3 Year -1.22% -1.14% 76.50% 75.11%

Aurobindo Pharma Ltd - STOCK STRENGTH

Today's Low/High 724.55
736.65
Week Low/High 711.10
740.00
Month Low/High 706.80
767.00
YEAR Low/High 660.10
1064.00
All TIME Low/High 0.56
1064.00
.